Business3 years ago
Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations
Boosted by the COVID vaccine, Moderna’s valuation has now leapfrogged that of well-established Big Pharma giants like Bristol Myers Squibb and Sanofi. Can it last? Read...
Recent Comments